Top Stock Picks for Week of November 9, 2026

Zacks
Zacks kaynağında aç
Top Stock Picks for Week of November 9, 2026

Advanced Micro Devices (AMD) has strengthened its position in the semiconductor market on the back of its strong product portfolio. AMD is benefiting from broadening AI infrastructure demand as EPYC server CPUs and Instinct accelerators gain traction across cloud and enterprise customers. Helios is beginning its production ramp, while multigigawatt commitments from leading model developers improve visibility into AI deployments. Venice strengthens the server roadmap, and management expects server growth to remain elevated into 2027. Client share gains and an Embedded recovery add diversification. For the current quarter, Advanced Micro is expected to post earnings indicating a change of +90.9% from the year-ago quarter. The Zacks Consensus Estimate has changed +14.1% over the last 30 days. For the current fiscal year, the consensus earnings estimate points to a change of +92.8% from the prior year. Over the last 30 days, this estimate has changed +6.8%. For the next fiscal year, the consensus earnings estimate of $17.28 indicates a change of +115% from what Advanced Micro is expected to report a year ago.

Moderna, Inc. (MRNA) is a commercial-stage pharmaceutical company primarily focused on discovering and developing messenger RNA (mRNA)-based therapies.European approval of the first influenza/COVID-19 combination vaccine and FDA approval of mFlusiva strengthen Moderna’s efforts to build a broader respiratory franchise beyond COVID-19. The Merck-partnered personalized cancer therapy has emerged as a potential growth driver after positive phase III melanoma data, with a possible 2027 launch. Pandemic-era COVID sales left Moderna with substantial cash to fund pipeline development across several therapeutic areas. Moderna’s collaboration model continues to support pipeline development by bringing in external funding, expertise and cost sharing. Moderna, Inc.raised its 2026 revenue outlook following stronger-than-expected third-quarter sales, supported by increased COVID vaccine demand, international partnerships and improved commercial execution. Third-quarter revenues increased 29% year over year exceeding the Zacks Consensus Estimate by 47.70%.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Advanced Micro Devices, Inc. (AMD): Free Stock Analysis Report
 
Moderna, Inc. (MRNA): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research